Skip to main content
SpringerLink
Log in

(Re)Imagining the Nation? Boosting Local Drug Development in Contemporary Russia

  • Chapter
  • First Online:
Health, Technologies, and Politics in Post-Soviet Settings

  • 191 Accesses

Abstract

This chapter examines recent government initiatives to boost innovative drug development and production in Russia and uncertainties that accompany these initiatives. The problem to be solved through the employment of pharmaceutical science and technology has been defined in economic terms and has focused largely on the local market. Ambitious policies and promises must be realised by such actors on the ground as academics and industrialists, who struggle with the rapid legislative change and pressing demands to deliver results. Focusing on complying with the new rules and trying to satisfy conditions for receiving state support, actors pay less attention to linking technoscientific developments with actual health needs. Their modes of navigating uncertainties allow them to survive in the rapidly shifting environment and continue their work but simultaneously may divorce drug development from public health and well-being.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Notes

  1. 1.

    For example, Viktor Dmitriev, Director of the Association of the Russian Pharmaceutical Manufacturers (ARPM), explained his vision of how production of these strategically important drugs could have been ensured. Officials from the Ministry of Industry and Trade should have arranged a meeting with producers and scientists and discussed who would assume responsibility for which of the strategic drugs. ‘Then we will see whether companies, science, have desire to do so or not. And if yes, then what is needed. […] Somebody would need a production line, others will need money to increase turnover volume so that from this turnover they finance the science part themselves. I think we need to begin from a meeting, where we would clearly work from the list: Bupivacaine—responsibility for its development is taken by such research centre or such company. Agree between each other, who does what, in which stage, make a business plan, which can be controlled via benchmarks, according to dates: what and when is done, when we will see the finalised drug. The most important is a plan. Each company that takes part in it needs to understand how it is going to develop the process, for which a business plan is needed. For each drug we need to appoint a responsible entity, deadlines […] and work accordingly. To distribute resources to develop drugs without specific details is equivalent, I think, to sending money into a black hole’ Shevchenko (2010).

References

  • Abrishami, P., Boer, A., & Horstman, K. (2015). How can we assess the value of complex medical innovations in practice? Expert Review of Pharmacoeconomics & Outcomes Research, 15(3), 369–371. doi:10.1586/14737167.2015.1037834.

    Article  Google Scholar 

  • Borup, M., Brown, N., Konrad, K., & van Lente, H. (2006). The sociology of expectations in science and technology. Technology Analysis and Strategic Management, 18(3/4), 285–298.

    Article  Google Scholar 

  • Brown, N., Rappert, B., & Webster, A. (Eds.). (2000). Contested futures: A sociology of prospective techno-science. Aldershot, UK: Ashgate.

    Google Scholar 

  • Conroy, M. S. (2006). The soviet pharmaceutical business during its first two decades (1917–1937). New York: Peter Lang Publishing.

    Google Scholar 

  • DSM Group. (2006). Russian pharmaceutical market in 2006. Word Journal of the International Linguistic Association. Retrieved from http://dsm.ru/docs/analytics/pharma_2006_eng.pdf

  • Elbe, S., Roemer-mahler, A., & Long, C. (2015). Medical countermeasures for national security: A new government role in the pharmaceuticalization of society. Social Science & Medicine, 131, 263–271. doi:10.1016/j.socscimed.2014.04.035.

    Article  Google Scholar 

  • Felt, U. (2015). Keeping technologies out: Sociotechnical imaginaries and the formation of Austria’s technopolitical identity. In S. Jasanoff & S.-H. Kim (Eds.), Dreamscapes of modernity: Sociotechnical imaginaries and the fabrication of power (pp. 103–125). Chicago: Chicago University Press.

    Google Scholar 

  • Freeman, C. (1995). The national system of innovation in historical perspective. Cambridge Journal of Economics, 19(1), 5–24.

    Google Scholar 

  • Gibbons, M., Limoges, C., Nowotny, H., Schwartzman, S., Scott, P., & Trow, M. (1994). The new production of knowledge: The dynamics of science and research in contemporary societies. London: SAGE Publications.

    Google Scholar 

  • Gordeev, A. I. (2009). The pharmaceutical industry in Russia: Reality and prospects. Acta Naturae, 3, 6–9. Retrieved from http://cyberleninka.ru/journal/n/acta-naturae-angloyazychnaya-versiya?issue_id=826913#issues-list-titleissues-list-title

  • Hecht, G. (2001). Technology, politics, and national identity in France. In M. T. Allen & G. Hecht (Eds.), Technologies of power (pp. 253–294). Cambridge, MA: MIT Press.

    Google Scholar 

  • Jack, D. B., & Mason, N. P. (1987). The pharmaceutical industry in the USSR. Journal of Clinical Pharmacy and Therapeutics, 12, 401–407. doi:10.2166/wh.2013.221.

    Article  Google Scholar 

  • Jasanoff, S. (Ed.). (2004). States of knowledge: The co-production of science and social order. London: Routledge.

    Google Scholar 

  • Jasanoff, S. (2005). Designs on nature: Science and democracy in Europe and the United States. Princeton: Princeton University Press.

    Book  Google Scholar 

  • Jasanoff, S. (2015). Future imperfect: Science, technology, and the imaginations of modernity. In S. Jasanoff & S.-H. Kim (Eds.), Dreamscapes of modernity: Sociotechnical imaginaries and the fabrication of power (pp. 1–33). Chicago: Chicago University Press.

    Chapter  Google Scholar 

  • Jasanoff, S., & Kim, S.-H. (2009). Containing the atom: Sociotechnical imaginaries and nuclear power in the United States and South Korea. Minerva, 47, 119–146. doi:10.1007/s11024-009-9124-4.

    Article  Google Scholar 

  • Metcalfe, S., & Ramlogan, R. (2008). Innovation systems and the competitive process in developing economies. Quarterly Review of Economics & Finance, 48(2), 433–446. doi:10.1016/j.qref.2006.12.021.

    Article  Google Scholar 

  • Minpromtorg. (2009). Strategy for the development of the pharmaceutical industry in the Russian Federation to 2020, Moscow.

    Google Scholar 

  • Minpromtorg. (2012). State Programme of the Russian Federation “Development of the pharmaceutical and medical industry” for 2013–2020, Moscow.

    Google Scholar 

  • Nelson, R. R. (1993). National innovation systems: A comparative analysis. New York: Oxford University Press.

    Google Scholar 

  • Neverova, O. (2016, November 14). Kurs vedet v glubiny [Going deeper]. Rossiiskaya Gazeta [Russian Newspaper]. Retrieved from https://rg.ru/2016/11/14/kak-prohodit-importozameshchenie-v-zdravoohranenii.html

  • Nikolaeva, D. (2016, April 28). Zapretnaya zona [No-go zone]. Kommersant. Retrieved from http://www.kommersant.ru/doc/2973282

  • Niosi, J., Saviotti, P., Bellon, B., & Crow, M. (1993). National systems of innovation: In search of a workable concept. Technology in Society, 15(2), 207–227.

    Article  Google Scholar 

  • OECD (Organization for Economic Cooperation and Development). (1994). Accessing and expanding the science and technology base. Paris: Organization for Economic Cooperation and Development.

    Google Scholar 

  • Pinch, T. J., & Bijker, W. E. (1987). The social construction of facts and artifacts: Or how the sociology of science and the sociology of technology might benefit each other. In W. E. Bijker, T. P. Hughes, & T. Pinch (Eds.), The social construction of technological systems: New directions in the sociology and history of technology (pp. 17–50). Cambridge, MA: The MIT Press.

    Google Scholar 

  • Reid, S. E., & Ramani, S. V. (2012). The harnessing of biotechnology in India: Which roads to travel? Technological Forecasting and Social Change, 79(4), 648–664. doi:10.1016/j.techfore.2011.12.008.

    Article  Google Scholar 

  • Satyibaldin, O. (2016, September 19). Proverki i porogi [Inspections and thresholds]. Rossiiskaya Gazeta [Russian Newspaper].

    Google Scholar 

  • Shevchenko. (2010). Strategichesky znachimye LS – Soglasno spisky [Strategically important drugs – according to the list]. Farmatsevticheskoe obozrenie, 9. Retrieved from http://www.alppp.ru/law/hozjajstvennaja-dejatelnost/promyshlennost/28/statja--strategicheski-znachimye-ls---soglasno-spisku.html

Download references

Author information

Authors and Affiliations

  1. Department of Health, Ethics and Society, Maastricht University, Maastricht, The Netherlands

    Olga Zvonareva

  2. Centre for Policy Analysis & Studies of Technologies, National Research Tomsk State University, Tomsk, Russian Federation

    Olga Zvonareva

  3. Central Research and Development Laboratory, Siberian State Medical University, Tomsk, Russian Federation

    Olga Zvonareva

Authors
  1. Olga Zvonareva
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Health, Ethics and Society, Maastricht University, Maastricht, The Netherlands

    Olga Zvonareva

  2. Centre for Policy Analysis & Studies of Technology, Tomsk State National Research University, Tomsk, Russia

    Evgeniya Popova

  3. Department of Health, Ethics and Society, Maastricht University, Maastricht, The Netherlands

    Klasien Horstman

Rights and permissions

Reprints and permissions

Copyright information

© 2018 The Author(s)

About this chapter

Cite this chapter

Zvonareva, O. (2018). (Re)Imagining the Nation? Boosting Local Drug Development in Contemporary Russia. In: Zvonareva, O., Popova, E., Horstman, K. (eds) Health, Technologies, and Politics in Post-Soviet Settings. Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-319-64149-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64149-2_3

  • Published:

  • Publisher Name: Palgrave Macmillan, Cham

  • Print ISBN: 978-3-319-64148-5

  • Online ISBN: 978-3-319-64149-2

  • eBook Packages: Social SciencesSocial Sciences (R0)

Publish with us

Policies and ethics

Search

Navigation